(GERD) L&G Gerd Kommer Multifactor - Overview

ETF Category: Global Large-Cap Blend Equity | Exchange: XETRA (Germany) | Market Cap: 1.368m EUR | Total Return: 25.1% in 12m

Global Equities, Diversified Stocks
Total Rating 64
Safety 48
Buy Signal -0.11
Global Large-Cap Blend Equity
Category Rotation: +1.9
TER: 0.45%
AUM: 1.59B
Avg Turnover: 2.41M
Risk 3d forecast
Volatility10.3%
VaR 5th Pctl1.91%
VaR vs Median3.18%
Reward TTM
Sharpe Ratio1.68
Rel. Str. IBD60.7
Rel. Str. Peer Group66
Character TTM
Beta0.628
Beta Downside0.610
Hurst Exponent0.491
Drawdowns 3y
Max DD19.22%
CAGR/Max DD0.90
CAGR/Mean DD7.67

Warnings

No concerns identified

Tailwinds

Supp Ema20

Description: GERD L&G Gerd Kommer Multifactor

The L&G Gerd Kommer Multifactor Equity UCITS ETF (GERD) tracks the Morningstar Global TME Index, providing diversified exposure to large- and mid-cap companies across developed and emerging markets. The fund utilizes a multifactor investment strategy, which systematically selects securities based on characteristics such as value, quality, momentum, and low size to potentially enhance risk-adjusted returns compared to traditional market-cap-weighted indices.

The multifactor business model aims to capture specific risk premiums that have historically outperformed the broader market over long horizons. By diversifying across multiple factors, the fund reduces reliance on any single market driver, a common approach in evidence-based investing designed to mitigate the cyclicality of individual factors like value or growth. For deeper insights into factor performance metrics, consider evaluating the funds holdings on ValueRay.

Headlines to Watch Out For
  • Multifactor weighting strategy outperformance relative to market-cap weighted benchmarks
  • Global equity market volatility impacts net asset value across developed and emerging regions
  • Interest rate fluctuations influence valuation multiples of diversified constituent holdings
  • Investor inflows drive total assets under management and fund liquidity levels
  • Morningstar Global TME index performance dictates underlying portfolio returns and tracking error
What is the price of GERD shares?

As of May 30, 2026, the stock is trading at EUR 14.72 with a total of 152,213 shares traded.
Over the past week, the price has changed by +1.24%, over one month by +6.67%, over three months by +7.43% and over the past year by +25.09%.

Is GERD a buy, sell or hold?

L&G Gerd Kommer Multifactor has no consensus analysts rating.